Form 8-K - Current report:
SEC Accession No. 0001104659-25-058141
Filing Date
2025-06-10
Accepted
2025-06-10 16:05:30
Documents
13
Period of Report
2025-06-10
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2517545d1_8k.htm   iXBRL 8-K 39175
  Complete submission text file 0001104659-25-058141.txt   254425

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA vacc-20250610.xsd EX-101.SCH 3528
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vacc-20250610_def.xml EX-101.DEF 26915
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE vacc-20250610_lab.xml EX-101.LAB 36557
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vacc-20250610_pre.xml EX-101.PRE 25539
15 EXTRACTED XBRL INSTANCE DOCUMENT tm2517545d1_8k_htm.xml XML 5491
Mailing Address UNIT 6-10, ZEUS BUILDING RUTHERFORD AVENUE, HARWELL DIDCOT X0 OX11 0DF
Business Address UNIT 6-10, ZEUS BUILDING RUTHERFORD AVENUE, HARWELL DIDCOT X0 OX11 0DF 44 (0) 1865 818808
Barinthus Biotherapeutics plc. (Filer) CIK: 0001828185 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40367 | Film No.: 251037099
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)